loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Asundexian, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Asundexian

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: Asundexian [inn], 2064121-65-7, La585um8de, 4-[[(2s)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide, Unii-la585um8de, Schembl20360602
    Molecular Formula
    C26H21ClF4N6O4
    Molecular Weight
    592.9  g/mol
    InChI Key
    XYWIPYBIIRTJMM-IBGZPJMESA-N
    FDA UNII
    LA585UM8DE
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide
    2.1.2 InChI
    InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1
    2.1.3 InChI Key
    XYWIPYBIIRTJMM-IBGZPJMESA-N
    2.1.4 Canonical SMILES
    CCC(C(=O)NC1=CC(=C(C=C1)C(=O)N)F)N2C=C(C(=CC2=O)C3=C(C=CC(=C3)Cl)N4C=C(N=N4)C(F)(F)F)OC
    2.1.5 Isomeric SMILES
    CC[C@@H](C(=O)NC1=CC(=C(C=C1)C(=O)N)F)N2C=C(C(=CC2=O)C3=C(C=CC(=C3)Cl)N4C=C(N=N4)C(F)(F)F)OC
    2.2 Other Identifiers
    2.2.1 UNII
    LA585UM8DE
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Asundexian [inn]

    2. 2064121-65-7

    3. La585um8de

    4. 4-[[(2s)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide

    5. Unii-la585um8de

    6. Schembl20360602

    7. Gtpl11710

    8. Bdbm413842

    9. Glxc-25353

    10. Ex-a6019

    11. Us10421742, Example 235

    12. Bay2433334

    13. Bay 2433334

    14. Bay-2433334

    15. Example 235 [wo2017005725a1]

    16. Hy-137431

    17. Cs-0138630

    18. 1(2h)-pyridineacetamide, N-(4-(aminocarbonyl)-3-fluorophenyl)-4-(5-chloro-2-(4-(trifluoromethyl)-1h-1,2,3-triazol-1-yl)phenyl)-.alpha.-ethyl-5-methoxy-2-oxo-, (.alpha.s)-

    19. 1(2h)-pyridineacetamide, N-(4-(aminocarbonyl)-3-fluorophenyl)-4-(5-chloro-2-(4-(trifluoromethyl)-1h-1,2,3-triazol-1-yl)phenyl)-alpha-ethyl-5-methoxy-2-oxo-, (alphas)-

    20. 4-({(2s)-2-[4-{5-chloro-2-[4-(trifluoromethyl)-1h-1,2,3-triazol-1-yl]phenyl}-5-methoxy-2-oxopyridin-1(2h)-yl]butanoyl}amino)-2-fluorobenzamide (enantiomer 2)

    2.4 Create Date
    2018-12-15
    3 Chemical and Physical Properties
    Molecular Weight 592.9 g/mol
    Molecular Formula C26H21ClF4N6O4
    XLogP33
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count8
    Exact Mass592.1248935 g/mol
    Monoisotopic Mass592.1248935 g/mol
    Topological Polar Surface Area132 Ų
    Heavy Atom Count41
    Formal Charge0
    Complexity1080
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY